Please use this identifier to cite or link to this item: http://localhost:80/xmlui/handle/123456789/14016
Full metadata record
DC FieldValueLanguage
dc.contributor.authorCao, Yingnan-
dc.contributor.authorTang, Qiling-
dc.contributor.authorLuo, Lan-
dc.contributor.authorGao, Ziying-
dc.date.accessioned2022-11-16T07:53:32Z-
dc.date.available2022-11-16T07:53:32Z-
dc.date.issued2018-05-20-
dc.identifier.citationCao, Y., Tang, Q., Luo, L., Gao, Z., & Zhang, S. (2018). A preliminary study on the anticancer efficacy of Caulis spatholobi compound 1802. Pakistan Journal of Pharmaceutical Sciences, 31.en_US
dc.identifier.issn1011-601X-
dc.identifier.urihttp://142.54.178.187:9060/xmlui/handle/123456789/14016-
dc.description.abstractIn recent years, antitumor and antiviral effect of Caulis spatholobi becomes a hot topic of medical drug research. Experiment shows that the water extract of Caulis spatholobi compound 1802 showed the effect of inhibiting tumor growth, the difference was statistically significant (P<0.05); the rate of tumor inhibition was highest in the high dose group of compound 1802, which could reach 41.99%. Anti tumor drugs generally have high toxicity, therefore, low toxicity is the significant characteristic of Caulis spatholobi. In particular the use of Caulis spatholobi has certain practical significance for development of tumor patients' daily diet products. In summary, the chemical constituents of Caulis spatholobi complex, has extensive pharmacological effects and clinical application.en_US
dc.language.isoenen_US
dc.publisherKarachi:Pakistan Journal of Pharmaceutical Sciences, university of Karachi.en_US
dc.subjectAntitumoren_US
dc.subjectlymphocyteen_US
dc.subjectCaulis spatholobien_US
dc.subjectCompound 1802.en_US
dc.titleA preliminary study on the anticancer efficacy of Caulis spatholobi compound 1802en_US
dc.typeArticleen_US
Appears in Collections:Issues No. 3 (Special)

Files in This Item:
File Description SizeFormat 
11-SP-6276.htm193 BHTMLView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.